Drug R&D Models Will Change Drastically By 2020, PwC Report Predicts
Executive Summary
The pharmaceutical industry is about to face a world in which successful companies no longer focus on blockbusters, drugs are approved in stages for an ever widening patient population, and large sales teams have been replaced by advisers, according to a report by PricewaterhouseCooper